TABLE 2.
CLINICAL CHARACTERISTICS (N=601)a
| Variable | Value, n (%) | |
|---|---|---|
| Mean OCI-R Score | 33.4±13.9, 1-72 | |
| Age of OCD Symptom Onset | 9.9±5.1, 1-30 | |
| Age of first cannabis use | 17.3±4.2, 6-46 | |
| Psychiatric Comorbidity - any | 481 (80.0) | |
| Generalized anxiety disorder | 334 (55.6) | |
| Major depressive disorder | 225 (37.4) | |
| Post-traumatic stress disorder | 166 (27.6) | |
| Social anxiety disorder | 151 (24.1) | |
| Personality disorder | 110 (18.3) | |
| Eating disorder | 100 (16.6) | |
| Panic disorder | 96 (16.0) | |
| Substance use disorder | 72 (12.0) | |
| Bipolar affective disorder | 59 (9.8) | |
| Autism spectrum disorder | 41 (6.8) | |
| Primary psychotic illness | 18 (3.0) | |
| Mean # of Psychiatric Comorbidities | 2.43 (SD: 2.03) | |
| Medical Comorbidity - any | 361 (60.1) | |
| Chronic pain | 131 (21.1) | |
| Migraine | 110 (18.3) | |
| Asthma | 94 (15.6) | |
| Thyroid disease | 38 (6.3) | |
| Mean # of Medical Comorbidities | 1.09 (SD: 1.26) | |
| Treatment History (N=601) | Current | Lifetime |
| Any Treatment | 226 (37.6) | 450 (74.9) |
| Medications | 188 (31.3) | 315 (52.4) |
| SRIs (SSRIs or clomipramine) | 155 (25.8) | 236 (39.3) |
| Psychotherapy | 100 (16.6) | 334 (55.5) |
| Residential | 4 (0.7) | 68 (11.3) |
| Transcranial Magnetic Stimulation | 2 (0.3) | 10 (1.8) |
| Alternative (mindfulness meditation, yoga, herbal supplements) | 162 (27.0) | 360 (59.9) |
| Lifetime Psychotherapy Treatment (N=334) | Value, n (%) | |
| Exposure and response prevention | 99 (16.5) | |
| Cognitive therapy (without exposure) | 257 (42.8) | |
| Acceptance and commitment therapy | 67 (11.1) | |
| Psychodynamic psychotherapy | 35 (5.8) | |
a
Includes only analyzed participants